| Literature DB >> 35441239 |
Nicholas N A Kyei1,2,3, Benedikt Cramer4, Hans-Ulrich Humpf4, Gisela H Degen5, Nurshad Ali6, Sabine Gabrysch7,8,9.
Abstract
Aflatoxins (AFs), ochratoxin A (OTA), citrinin (CIT), fumonisin B1 (FB1), zearalenone (ZEN), and deoxynivalenol (DON) are mycotoxins that may contaminate diets, especially in low-income settings, with potentially severe health consequences. This study investigates the exposure of 439 pregnant women in rural Bangladesh to 35 mycotoxins and their corresponding health risks and links their exposure to certain foods and local stimulants. Overall, 447 first-morning urine samples were collected from pregnant women between July 2018 and November 2019. Mycotoxin biomarkers were quantified by DaS-HPLC-MS/MS. Urinary concentration of frequently occurring mycotoxins was used to estimate dietary mycotoxin exposure. Median regression analyses were performed to investigate the association between the consumption of certain foods and local stimulants, and urinary concentration of frequently occurring mycotoxins. Only in 17 of 447 urine samples (4%) were none of the investigated mycotoxins detected. Biomarkers for six major mycotoxins (AFs, CIT, DON, FB1, OTA, and ZEN) were detected in the urine samples. OTA (95%), CIT (61%), and DON (6%) were most frequently detected, with multiple mycotoxins co-occurring in 281/447 (63%) of urine samples. Under the lowest exposure scenario, dietary exposure to OTA, CIT, and DON was of public health concern in 95%, 16%, and 1% of the pregnant women, respectively. Consumption of specific foods and local stimulants-betel nut, betel leaf, and chewing tobacco-were associated with OTA, CIT, and DON urine levels. In conclusion, exposure to multiple mycotoxins during early pregnancy is widespread in this rural community and represents a potential health risk for mothers and their offspring.Entities:
Keywords: Exposure assessment; Human biomonitoring; Mycotoxins; Pregnant women; Risk assessment; Rural areas; Urine
Mesh:
Substances:
Year: 2022 PMID: 35441239 PMCID: PMC9151532 DOI: 10.1007/s00204-022-03288-0
Source DB: PubMed Journal: Arch Toxicol ISSN: 0340-5761 Impact factor: 6.168
Instrumental limits of mycotoxin biomarker concentrations in urine in ng/ml
| 35 Mycotoxin biomarkers | LOD | LOQ |
|---|---|---|
| Aflatoxin B1 (AFB1) | 0.06 | 0.2 |
| Aflatoxin B2 (AFB2) | 0.04 | 0.12 |
| Aflatoxin M1 (AFM1) | 0.1 | 0.3 |
| Aflatoxin G1 (AFG1) | 0.7 | 2 |
| Aflatoxin G2 (AFG2) | 0.2 | 0.6 |
| Alternariol (AOH) | 3 | 10 |
| Alternariol monomethyl ether (AME) | 0.3 | 1 |
| Altenuene (ALT) | 1.7 | 5 |
| Beauvericin (BEA) | 1 | 2.5 |
| Citrinin (CIT) | 0.17 | 0.5 |
| Deoxynivalenol (DON) | 1.7 | 5 |
| Deoxynivalenol-3-glucuronide (DON-3-GlcA) | 2.5 | 7.5 |
| Deoxynivalenol-15-glucuronide (DON-15-GlcA) | 2.5 | 7.5 |
| Dihydrocitrinone (HO-CIT) | 0.1 | 0.3 |
| Enniatin B (ENB) | 0.025 | 0.075 |
| Enniatin B1 (ENB1) | 0.125 | 0.375 |
| Enniatin A (ENA) | 0.06 | 0.175 |
| Enniatin A1 (ENA1) | 0.12 | 0.35 |
| Fumonisin B1 (FB1) | 1 | 3 |
| Fumonisin B2 (FB2) | 30 | 100 |
| HT2-toxin (HT2) | 8 | 25 |
| HT2-toxin-3-glucuronide (HT-2–3-GlcA) | 1.7 | 5 |
| HT2-toxin-4-glucuronide (HT-2–4-GlcA) | 1.3 | 4 |
| Hydroxy-Ochratoxin A (OH-OTA) | 0.05 | 0.15 |
| Ochratoxin A (OTA) | 0.02 | 0.06 |
| 2'R-Ochratoxin A (2'R-OTA) | 0.01 | 0.03 |
| Ochratoxin alpha (OTalpha) | 0.2 | 0.6 |
| T2-toxin (T2) | 0.2 | 0.6 |
| Zearalenone (ZEN) | 0.7 | 2 |
| Zearalenone (ZAN) | 1.25 | 3.75 |
| Zearalanone-14-glucuronide (ZAN-14-GlcA) | 7 | 20 |
| Zearalenone-14-glucuronide (ZEN-14-GlcA) | 7 | 20 |
| alpha-Zearalenol-14-glucuronide (alpha-ZEL-14) | 3 | 10 |
| beta-Zearalenol-14-glucuronide (beta-ZEL-14) | 7 | 20 |
| Zearalenone-14-sulfate (ZEN-14-SO4) | 0.3 | 1 |
LOD limit of detection, LOQ limit of quantification
Direction of crude associations between consumption of certain foods/stimulants and frequently detected mycotoxins in urine samples of pregnant women in rural Habiganj district, Bangladesh (N = 443)
| Food group / Stimulant | OTA | ||||||
|---|---|---|---|---|---|---|---|
| ß sign | ß sign | ß sign | |||||
| Starches (Yes > 15 g, past 24h) | 443 | ||||||
| Pulses (Yes > 15 g, past 24h) | 139 | + | 0.43 | + | 0.47 | ± | 1.00 |
| Nuts/seeds (Yes > 15 g, past 24h) | 41 | + | < 0.001 | + | 0.77 | ± | 1.00 |
| Dark green leafy vegetables (Yes > 15 g, past 24h) | 142 | + | 0.05 | + | 0.73 | ± | 1.00 |
| Vitamin A-rich fruits (Yes > 15 g, past 24h) | 47 | + | 0.13 | – | 0.34 | ± | 1.00 |
| Vitamin A-rich vegetables (Yes > 15 g, past 24h) | 27 | + | 0.86 | – | 0.91 | + | 0.04 |
| Vitamin C-rich fruits (Yes > 15 g, past 24h) | 171 | + | 0.46 | + | 0.42 | – | 0.07 |
| Vitamin C-rich vegetables (Yes > 15 g, past 24h) | 146 | – | 0.06 | + | 0.95 | ± | 1.00 |
| Eggs (Yes > 15 g, past 24h) | 75 | – | 0.03 | + | 0.33 | – | 0.23 |
| Organ meat (Yes > 15 g, past 24h) | 12 | + | 0.68 | – | 0.20 | ± | 1.00 |
| Small fish (Yes > 15 g) | 306 | + | 0.38 | + | 0.18 | – | 0.06 |
| Large fish/seafood (Yes > 15 g, past 24h) | 219 | – | 0.04 | – | 0.34 | ± | 1.00 |
| Flesh foods (Yes > 15 g, past 24h) | 66 | + | 0.80 | – | 0.02 | ± | 1.00 |
| Dairy (Yes > 15 g, past 24h) | 129 | – | 0.61 | – | 0.14 | ± | 1.00 |
| Edible oil (Yes > 15 g, past 24h) | 437 | – | 0.05 | – | 0.18 | + | 0.67 |
| Sugary foods (Yes > 15 g, past 24h) | 292 | – | 0.01 | + | 0.27 | + | 0.08 |
| Condiments/spices (Yes > 15 g, past 24h) | 440 | – | 0.45 | – | 0.85 | – | 0.70 |
| Tea or coffee** (Yes > 15 g, past 24h) | 232 | – | 0.01 | – | 0.95 | + | 0.06 |
| Betel leaf ( | 258 | + | 0.03 | + | 0.001 | + | 0.07 |
| Betelnut (Yes, past 4 weeks) | 263 | + | 0.07 | + | 0.03 | + | 0.04 |
| Betelnut and | 257 | + | 0.04 | + | 0.01 | + | 0.07 |
| Chewing obacco ( | 193 | + | 0.01 | + | 0.02 | + | < 0.001 |
ß sign – the direction of association (positive ( +) or negative (–)) from beta-coefficients; * p-values from crude median regression analyses using bootstrapping over 1000 replications; n number of consumers, na—not analyzed; tCIT- total CIT (CIT + HO-CIT); tDON—total DON (DON + DON-Glucuronides); **In the study region, tea is consumed much more frequently than coffee, ± means no change in coefficient; h-hours
Sociodemographic characteristics of study population
| Characteristic | Percent | ||
|---|---|---|---|
| 439 | |||
| Muslim | 331 | 75 | |
| Hindu | 108 | 25 | |
| 439 | |||
| Poorest | 6 | 1 | |
| Lower | 44 | 10 | |
| Middle | 169 | 39 | |
| Upper | 174 | 40 | |
| Wealthiest | 46 | 10 | |
| 439 | |||
| No formal education | 62 | 14 | |
| Partial primary | 121 | 28 | |
| Complete primary | 99 | 23 | |
| Partial secondary | 134 | 31 | |
| Completed secondary | 12 | 3 | |
| Post-secondary | 11 | 3 | |
| 447 | |||
| January–April | 112 | 25 | |
| May–August | 188 | 42 | |
| September–December | 147 | 33 | |
| Mean | SD | ||
| Woman’s height (cm) | 439 | 150 | 6 |
| Woman’s age at first marriage (years) | 435 | 18 | 2 |
| Woman's age at enrollment (years) | 447 | 27 | 4 |
| Gestational age at enrollment (weeks) | 447 | 15 | 6 |
| Woman's weight at enrollment (kg) | 447 | 47 | 8 |
| Urine creatinine concentration (mg/100 ml) | 447 | 61 | 42 |
| Urine density (g/ml) | 447 | 1.010 | 0.005 |
1This is not a relative wealth quintile, but the estimate of the households’ national wealth quintile if the assets owned in 2019 were in the 2014 DHS survey (constructed using https://www.equitytool.org), SD Standard deviation; *Differences in numbers as some variables are women characteristics and others pregnancy characteristics
Occurrence and concentration of mycotoxin biomarkers in urine samples of pregnant women in rural Habiganj district, Bangladesh (n = 447)
| Mycotoxin / metabolite | Instrumental limits for biomarkers in urine (ng/ml) | Total detected ≥ LOD | Total detected > LOQ | Positive detection (%) | Uncorrected concentration in urine (ng/ml) | |||
|---|---|---|---|---|---|---|---|---|
| LOD | LOQ | Mean | Min | Max | ||||
| AFB2 | 0.04 | 0.12 | 1 | 0 | < 1 | – | – | – |
| AFM1 | 0.10 | 0.30 | 7 | 1 | 1.6 | 0.42 | – | – |
| CIT | 0.17 | 0.50 | 183 | 131 | 41 | 2.46 | 0.58 | 14.54 |
| HO-CIT | 0.10 | 0.30 | 229 | 82 | 51 | 1.36 | 0.30 | 10.31 |
| – | – | 274 | – | 61 | ||||
| DON | 1.70 | 5.00 | 18 | 2 | 4.0 | 8.04 | 3.14 | 25.59 |
| DON-3-GlcA | 2.50 | 7.50 | 1 | 1 | < 1 | – | – | – |
| DON-15-GlcA | 2.50 | 7.50 | 12 | 12 | 2.7 | 79.77 | 8.3 | 181.7 |
| – | – | 27 | – | 6.0 | ||||
| FB1 | 1.00 | 3.00 | 1 | 1 | < 1 | 9.12 | – | – |
| OTA | 0.02 | 0.06 | 424 | 346 | 95 | 0.32 | 0.06 | 2.93 |
| ZEN-14-SO4 | 0.30 | 1.00 | 1 | 0 | < 1 | – | – | – |
Positive samples refer to samples containing the analyte ≥ stated limit of detection (LOD). Only positive samples > LOQ are considered in calculating mean concentrations where applicable; tCIT- total CIT (CIT + HO-CIT); tDON- total DON (DON + DON-Glucuronides)
Fig. 1Number of detected biomarkers and mycotoxins in urine samples of pregnant women in rural Bangladesh (n = 447). Only in 17 urine samples (4%) none of the investigated mycotoxins were detected. About a third of the urine samples contained one, a third two, and another third three detectable mycotoxin biomarkers. Only 2% contained more than three. (Figure 1a). This corresponds to two different mycotoxins detected in over half and three in 5% of the samples, while a third of samples contained one detectable mycotoxin. (Figure 1b). tCIT- total CIT (CIT+ HO-CIT); tDON- total DON (DON + DON-Glucuronides); tAF- total aflatoxins (AFM1+AFB2)
Fig. 2Mycotoxin combinations and their occurrence in urine samples of pregnant women in rural Bangladesh (n = 447). Biomarkers for six major mycotoxins (AFs, CIT, DON, FB1, OTA, and ZEN) were detected in the urine samples. Co-occurrence of multiple mycotoxins was detected in 281/447 (63%) of urine samples. Co-occurrence of OTA and CIT was the prevailing co-exposure (55%)
Estimated probable daily intake of four frequently occurring mycotoxins/metabolites under different substitution scenarios and with adjustment for urine density and creatinine concentration (n = 447)
| Left-censorship substitution | Mycotoxin | PDI (ng/kg bw/day) density-adjusted | PDI (ng/kg bw/day) creatinine-adjusted | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Mean | Standard deviation | Maximum | Health concern* | Mean | Standard deviation | Maximum | Health concern | ||
| LB | 116 | 270 | 2885 | 74 (16) | 210 | 484 | 4557 | 111 (25) | |
| 25 | 260 | 4943 | 3 (1) | 40 | 373 | 5359 | 4 (1) | ||
| OTA | 400 | 466 | 3968 | 424 (95) | 704 | 842 | 8070 | 424 (95) | |
| MB | 131 | 265 | 2885 | 75 (17) | 238 | 477 | 4557 | 116 (26) | |
| 229 | 290 | 4967 | 4 (1) | 435 | 572 | 8062 | 21 (5) | ||
| OTA | 407 | 461 | 3968 | 447 (100) | 720 | 832 | 8070 | 447 (100) | |
| UB | 152 | 261 | 2885 | 83 (19) | 279 | 473 | 4557 | 149 (33) | |
| 438 | 385 | 4992 | 20 (4) | 838 | 968 | 16,123 | 107 (24) | ||
| OTA | 426 | 451 | 3968 | 447 (100) | 757 | 816 | 8070 | 447 (100) | |
PDI probable daily intake, eqv equivalents, LB lower bound substitution, MB middle bound substitution, UB upper bound substitution, na not available, *Health concern- Hazard quotient > 1 for CIT and DON and Margin of Exposure < 10,000 for OTA, Tolerable daily intake – for CIT: 200 ng/kg bw and for DON:1000 ng/kg bw, tCIT- total CIT (CIT + HO-CIT), tDON- total DON (DON + DON-Glucuronides)
Fig.
3Margin of Exposure of pregnant women to dietary ochratoxin A under the lowest exposure scenario (n = 447). The Margin of Exposure (MOE) is calculated by dividing the benchmark dose lower confidence limit (BMDL10) for ochratoxin A (OTA; 14.5 µg/kg body weight/day) by the woman's exposure which is estimated by probable daily intake (PDI). The red line shows a MOE of 10,000. If the MOE is below 10,000, the exposure could be of health concern. Dietary exposure to OTA is below this line in 95% of pregnant women in our sample
Fig. 4Hazard quotient of dietary exposure of pregnant women to citrinin (n = 447) under a moderate exposure scenario. The Hazard quotient (HQ) is calculated by dividing individual exposure, measured by probable daily intake (PDI) by the established tolerable daily intake (TDI) level for citrinin (CIT; 200 ng/kg body weight/day). The red line shows a HQ of 1. If the HQ is above 1, the exposure could be of health concern. The exposure of 17% of the pregnant women in our sample is of public health concern